Published in Cardiovasc Res on January 18, 2010
A novel biclustering approach to association rule mining for predicting HIV-1-human protein interactions. PLoS One (2012) 1.11
Slit2/Robo4 signaling modulates HIV-1 gp120-induced lymphatic hyperpermeability. PLoS Pathog (2012) 0.92
Probability weighted ensemble transfer learning for predicting interactions between HIV-1 and human proteins. PLoS One (2013) 0.88
Inflammation, immune activation, and cardiovascular disease in HIV. AIDS (2016) 0.87
Pentoxifylline reduces tumor necrosis factor-α and HIV-induced vascular endothelial activation. AIDS Res Hum Retroviruses (2012) 0.84
Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17. Pathog Dis (2015) 0.81
Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat. Cardiovasc Pathol (2015) 0.79
HIV envelope protein gp120-induced apoptosis in lung microvascular endothelial cells by concerted upregulation of EMAP II and its receptor, CXCR3. Am J Physiol Lung Cell Mol Physiol (2013) 0.78
Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk? World J Cardiol (2015) 0.77
Brachial and central blood pressure in HIV-infected subjects. Hypertens Res (2015) 0.77
HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking. Retrovirology (2015) 0.77
What happens to cardiovascular system behind the undetectable level of HIV viremia? AIDS Res Ther (2016) 0.75
Human immunodeficiency virus-associated disruption of mucosal barriers and its role in HIV transmission and pathogenesis of HIV/AIDS disease. Tissue Barriers (2016) 0.75
Study of Basic Coagulation Parameters among HIV Patients in Correlation to CD4 Counts and ART Status. J Clin Diagn Res (2016) 0.75
Prolonged Morphine Exposure Induces Increased Firm Adhesion in an in Vitro Model of the Blood-Brain Barrier. Int J Mol Sci (2016) 0.75
The P2X7 Receptor Involved in gp120-Induced Cell Injury in BV2 Microglia. Inflammation (2016) 0.75
Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol (1986) 10.92
Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol (1986) 8.22
Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS (2009) 3.08
Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther (2001) 2.74
Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis (2007) 2.16
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res (1993) 1.98
Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr (1992) 1.95
ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines. J Immunol (2000) 1.92
Cardiovascular disease in HIV infection. Am Heart J (2006) 1.78
Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway. J Biol Chem (1999) 1.74
Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration. J Immunol (2006) 1.51
Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vascul Pharmacol (2008) 1.45
Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J Biol Chem (2003) 1.41
Pathogenesis of HIV-associated cardiovascular complications. Lancet Infect Dis (2001) 1.38
Host determinants in HIV infection and disease. Part 2: genetic factors and implications for antiretroviral therapeutics. Ann Intern Med (2001) 1.24
Induction of endothelial NO synthase by hydrogen peroxide via a Ca(2+)/calmodulin-dependent protein kinase II/janus kinase 2-dependent pathway. Arterioscler Thromb Vasc Biol (2001) 1.18
Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins. Biochem Biophys Res Commun (2005) 1.17
Current update on HIV-associated vascular disease and endothelial dysfunction. World J Surg (2007) 1.15
Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells. Blood (2008) 1.15
HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases. Blood (2000) 1.12
Endothelial signaling by Ig-like cell adhesion molecules. Arterioscler Thromb Vasc Biol (2007) 1.05
Hiv Tat protein causes endothelial dysfunction in porcine coronary arteries. J Vasc Surg (2003) 1.03
HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells. Lab Invest (2002) 1.01
Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells. J Neurovirol (2008) 1.01
Up-regulation of endothelial nitric-oxide synthase promoter by the phosphatidylinositol 3-kinase gamma /Janus kinase 2/MEK-1-dependent pathway. J Biol Chem (2001) 1.00
Reactive oxygen species generated by glia are responsible for neuron death induced by human immunodeficiency virus-glycoprotein 120 in vitro. Neuroscience (2001) 0.98
Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration. Am J Physiol Heart Circ Physiol (2008) 0.97
HIV Nef protein causes endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial cells. J Surg Res (2009) 0.96
Circulating cell adhesion molecules in HIV1-infected patients as indicator markers for AIDS progression. Res Immunol (1997) 0.90
HIV-associated coronary arteritis in a patient with fatal myocardial infarction. N Engl J Med (2001) 0.84
Gatekeeper role of 14-3-3tau protein in HIV-1 gp120-mediated apoptosis of human endothelial cells by inactivation of Bad. AIDS (2007) 0.84
Soluble intercellular adhesion molecule-1 (sICAM-1) and vascular cell adhesion molecule-1 (sVCAM-1) in patients with HIV/AIDS does not appear to correlate with cytomegalovirus retinitis. Int J STD AIDS (1998) 0.81
Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial. JAMA (2009) 6.11
Shear stress induces endothelial differentiation from a murine embryonic mesenchymal progenitor cell line. Arterioscler Thromb Vasc Biol (2005) 2.51
Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol (2009) 2.44
Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn (2009) 2.35
Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg (2009) 2.31
A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med (2013) 2.11
Trop2: a possible therapeutic target for late stage epithelial carcinomas. Biochim Biophys Acta (2009) 2.08
Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Mol Cancer Ther (2008) 1.90
Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A (2007) 1.81
HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells. Arterioscler Thromb Vasc Biol (2002) 1.78
Outcomes of endovascular repair of ruptured descending thoracic aortic aneurysms. Circulation (2010) 1.65
ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenografts. Cancer Biol Ther (2010) 1.63
Thoracic or thoracoabdominal approaches to endovascular device removal and open aortic repair. Ann Thorac Surg (2012) 1.62
MicroRNA-196: critical roles and clinical applications in development and cancer. J Cell Mol Med (2011) 1.59
Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer (2006) 1.59
A single nucleotide polymorphism in the matrix metalloproteinase 9 gene (-8202A/G) is associated with thoracic aortic aneurysms and thoracic aortic dissection. J Thorac Cardiovasc Surg (2006) 1.57
Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J Cell Mol Med (2009) 1.51
Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. Am J Pathol (2002) 1.46
Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves. J Surg Res (2005) 1.45
Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res (2006) 1.45
Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res (2007) 1.43
Open surgery versus endovascular repair of ruptured thoracic aortic aneurysms. J Vasc Surg (2011) 1.43
Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer (2010) 1.43
Emergent embolization of the gastroduodenal artery in the treatment of upper gastrointestinal bleeding. The experience from a surgeon-initiated interventional program. Am J Surg (2009) 1.42
Management of inadvertent carotid artery sheath insertion during central venous catheter placement. JAMA Surg (2013) 1.41
Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans. Virology (2010) 1.40
Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. Med Sci Monit (2005) 1.37
Overcoming drug resistance in pancreatic cancer. Expert Opin Ther Targets (2011) 1.36
Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction. J Acquir Immune Defic Syndr (2007) 1.32
Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts. Clin Cancer Res (2009) 1.30
Development of small-diameter vascular grafts. World J Surg (2007) 1.27
Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Med Sci Monit (2010) 1.24
Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. Cancer (2004) 1.22
Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol (2012) 1.22
Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation. Carcinogenesis (2011) 1.20
Ceramide: a common pathway for atherosclerosis? Atherosclerosis (2007) 1.19
Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3. Mol Cancer Res (2008) 1.19
Human immunodeficiency virus protease inhibitor ritonavir inhibits cholesterol efflux from human macrophage-derived foam cells. Am J Pathol (2007) 1.17
A prospective evaluation of hypogastric artery embolization in endovascular aortoiliac aneurysm repair. J Vasc Surg (2002) 1.16
Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes. J Immunother (2009) 1.16
Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res (2005) 1.16
Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression. Mol Cancer (2011) 1.16
Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation. J Pharmacol Exp Ther (2012) 1.16
Current update on HIV-associated vascular disease and endothelial dysfunction. World J Surg (2007) 1.15
Expression and function of a large non-coding RNA gene XIST in human cancer. World J Surg (2011) 1.15
Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells. Blood (2008) 1.15
Roles of cyclophilins in cancers and other organ systems. World J Surg (2005) 1.14
ZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB. Clin Cancer Res (2010) 1.13
MicroRNAs: control and loss of control in human physiology and disease. World J Surg (2009) 1.12
Determinants of mortality and treatment outcome following surgical interventions for acute mesenteric ischemia. J Vasc Surg (2007) 1.11
Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications. Expert Opin Ther Targets (2008) 1.11
Human stanniocalcin-1 blocks TNF-alpha-induced monolayer permeability in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol (2008) 1.09
Cyclophilin A: potential functions and therapeutic target for human cancer. Med Sci Monit (2009) 1.09